At the peak of the crisis, unemployment in U.S. was hovering around 10%, which is clearly not being considered as healthy and Federal Reserve has taken unprecedented steps in monetary policy easing to tackle the unemployment, since dual mandate of FED includes maximum employment possible under price stability. Unemployment rate in Euro zone currently stands at 11.1%.
However on the other hand European Central Bank (ECB) has also taken up unconventional policy easing but at the sake of fragmentation.
However, without any central co-ordination from the fiscal side ECB alone is unlikely to succeed even if it wants to lower unemployment.
As of now, it is quite clear from the unemployment rate that Euro zone is far away from economic activities which can be labelled as normal.
European Central Bank (ECB) and fiscal authorities need not only to focus on monetary policy fragmentation but employment fragmentation.
- As of latest report, unemployment rates are extremely fragmented. While unemployment rate is at 4.7% in Germany, 5.5% in Malta, 5.7% in Luxembourg, 6% in Austria, rates are way higher in France (10.2%), Italy (12.7%) and Spain (22.5%). We are not even talking Greece and youth unemployment.
Unless this issue is tackled, Euro zone will keep facing challenges from Euro-skeptics, who are clearly on the rise across Europe.


Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
FxWirePro- Major Crypto levels and bias summary
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand
BTC Flat at $89,300 Despite $1.02B ETF Exodus — Buy the Dip Toward $107K?
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



